Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avamys for exercise-induced airway obstruction in children with allergic asthma
NL-OMON33344Phase 4Active, not recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinitis (AR), asthma and exercise-induced bronchospasm (EIB) comparing Avamys with Placebo (2 arms). Primary endpoints: Reduction in exercise-induced fall in FEV1 and Reduction in exercise-induced fall in MIF50. Started Oct 2009; status: active, not recruiting.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)asthmaexercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NL-OMON33344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33344.